Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol AFP contributors: mct - updated : 12-07-2015
HGNC name alpha-fetoprotein
HGNC id 317
EXPRESSION
Type widely
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Cardiovascularheart   highly
Digestiveliver   highly
Lymphoid/Immunespleen   highly
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period embryo, fetal, pregnancy
Text hepatocytes, lowly in gut/reactivated during liver regeneration liver at the early, yolk sac, visceral endoderm, developing mesonephros
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • three albumin domains
    • conjugated GlycoP
    mono polymer monomer , dimer
    HOMOLOGY
    interspecies homolog to dog AFP (84.07 pc)
    Homologene
    FAMILY ALB/AFP/VDB family
    CATEGORY immunity/defense , protooncogene
    SUBCELLULAR LOCALIZATION extracellular
        intracellular
    intracellular,cytoplasm
    basic FUNCTION
  • major plasma protein produced by the yolk sac and the liver during fetal life
  • involved in targeting positive regulation of the apoptotic pathway dysfunction in cancer cells inhibiting the apoptosis protein function inhibitor, leading to triggering of apoptosis machinery
  • oncoembryonic protein inducing dose-dependent targeting apoptosis in tumor cells, accompanied by cytochrome c release and caspase 3 activation
  • may modulate inflammatory events in human skin
  • can induce apoptosis or impair monocyte-derived dendritic cell (MDDC) function
  • plays a signal molecule-like role in the regulation of hepatocellular carcinoma growth
  • antagonizes X-linked inhibitor of apoptosis protein XIAP anticaspase activity and disrupts XIAP-caspase interaction
  • its level in the plasma is apparently related to monocyte activation
  • may be involved in multiple cell growth regulating, differentiating, and immunosuppressive activities
  • AFP functions as a regulator in the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway
    • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule other,
  • copper
  • nickel
  • fatty acids
    • protein
  • LHX4 may act as a potential tumor suppressor in hepatocarcinogenesis (LHX4 expression increased in adult liver in a manner that parallel AFP repression), suggesting that targeting LHX4 to downregulate AFP might have therapeutic implications
  • because of its ability to suppress AFP gene transcription in hepatic cells, ZFHX3 is a factor associated with differentiation of the hepatocyte
  • strong interaction between AFP and PTEN (phosphatase and tensin homolog), demonstrating that AFP did bind to PTEN
  • ZBTB20 is a sequence-specific transcriptional repressor of AFP
    • cell & other
    REGULATION
    induced by
  • CEBPA by direct binding to the promoter and enhancer
    • regions of the AFP gene
    repressed by ZHX2, that contributes to AFP repression in the liver after birth and may also be involved in AFP reactivation in liver cancer
    Other enhanced expression of AFP by NKX2-8
    ASSOCIATED DISORDERS
    corresponding disease(s) AFP
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral       gain of function
    differentially upregulated in yolk sac tumors of germ cells
    tumoral     --over  
    in the majority of hepatocellular carcinomas
    constitutional     --over  
    in ASD (autism spectrum disorders)
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
  • AFP is a good candidate for further larger-scale studies to confirm such an association and to determine whether this pattern is unique to ASD or related to other psychiatric disorders as well
  • low AFP levels and increased CA 19-9 levels can be used as tumor markers in diagnosis of molar pregnancies in conjunction with clinical and sonographic findings and serum levels of HCG
    • Therapy target
    ANIMAL & CELL MODELS